Antibiotic Resistance Determination Utilizing Machine Learning
Antibiotic Resistance Determination Utilizing Machine Learning
批准号:
10442982
负责人:
David Elihu Greenberg
金额:
$45.92万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-07-12 至 2025-04-30
关键词:
AlgorithmsAntibiotic ResistanceAntibiotic susceptibilityAntibioticsAntimicrobial susceptibilityArtificial IntelligenceBacteriaBacterial Antibiotic ResistanceBacterial Drug ResistanceBacterial GenomeBacterial InfectionsBiological AssayClinicalCollectionCombined AntibioticsCommunicable DiseasesCommunitiesCulture TechniquesCustomCystic FibrosisDataData CollectionData ScienceDevelopmentDiagnosisDiagnosticElectronic Health RecordEnsureEpidemiologyFaceFeedbackFoundationsGenerationsGoalsIndividualInfrastructureLaboratoriesLeadMachine LearningMass Spectrum AnalysisMethodologyMethodsModelingMolecularOnline SystemsOrganismOutputPatient CarePatientsPatternPerformancePharmaceutical PreparationsPhenotypePhysiciansProceduresProcessProteinsPublic HealthPulmonary Cystic FibrosisReproducibilityResearchResearch PersonnelResistanceResistance developmentResourcesSamplingSolidSpecimenSpeedTechniquesTechnologyTest ResultTestingTimeValidationVariantVisualization softwareWorkalgorithm developmentantimicrobialbasechronic infectioncloud basedcohortcommunity engagementcomputerized toolscostdeep learningdeep learning modeldesigneffective therapyemerging pathogenfallsgenome sequencinggenomic datain silicoinfectious disease treatmentinformatics toolinnovationinterestlarge datasetsmachine learning algorithmmachine learning modelmachine learning predictionmicrobialnovelonline resourceopen sourcepathogenpathogenic bacteriaphenotypic dataprediction algorithmpredictive modelingprogramsprospectiveresistance mechanismtooltool developmenttransfer learningusabilityuser-friendlyweb sitewhole genome
中文摘要
摘要
我们的长期目标是通过开发准确和可解释的预测来解决抗生素耐药性问题
机器学习模型,可以用于临床,以加快细菌感染患者的护理。
目前诊断细菌感染的方法依赖于首先从收集的样本中培养病原体。
然后进行各种表型测试,以确定特定细菌分离物的抗生素
敏感的或抗拒的。在许多情况下,这一过程可能需要几天时间才能完成。开发一种准确的方法来
利用全基因组测序数据预测抗生素耐药性,而不需要表型测试
这个项目的总体目标。我们的团队应用了深度学习和云计算的最新进展。
我们将追求以下具体目标:1)管理大型数据集并开发深度学习预测
对多种细菌种类和抗生素组合具有最先进精度的模型;2)
为慢性感染开发个性化的机器学习模型;3)创建开源的可扩展用户-
为广大研究社区提供友好的资源。这项工作的成功完成将为
我们诊断细菌感染的方式发生了范式转变,并加快了提供正确的
针对特定病原体的抗生素。
英文摘要
Summary
Our long-term objective is to tackle antibiotic resistance by developing accurate and interpretable prediction
machine learning models that could be used clinically to speed up the care of patients with bacterial infections.
Current approaches to diagnosing bacterial infections rely on first culturing a pathogen from a collected specimen
followed by a variety of phenotypic tests to determine what antibiotic a particular bacterial isolate would be
sensitive or resistant to. This process can, in many cases, take days to finish. Developing an accurate way to
predict antibiotic resistance utilizing whole-genome sequencing data without the need for phenotypic testing is
the overall goal of this project. Our team applies the latest advances in deep learning and cloud computation.
We will pursue the following Specific Aims: 1) Curate a large dataset and develop a deep-learning prediction
model with state-of-the-art accuracies for a wide range of bacterial species and antibiotic combinations; 2)
Develop personalized machine learning models for chronic infections; 3) create open-sourced scalable user-
friendly resources for the broad research community. The successful completion of this work will provide a
paradigm shift in the way we diagnose bacterial infections and speed up the time to providing the correct
antibiotic for a specific pathogen.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Antibiotic Resistance Determination Utilizing Machine Learning
-
批准号:10663905
-
项目类别:
-
资助金额:$47.87万
-
财政年份:2022
-
负责人:David Elihu Greenberg
-
依托单位:
Development of Gene-Silencing Therapeutics for Pseudomonas aeruginosa
-
批准号:10203746
-
项目类别:
-
资助金额:$105.77万
-
财政年份:2019
-
负责人:David Elihu Greenberg
-
依托单位:
Development of Gene-Silencing Therapeutics for Pseudomonas aeruginosa
-
批准号:10451560
-
项目类别:
-
资助金额:$112.55万
-
财政年份:2019
-
负责人:David Elihu Greenberg
-
依托单位:
Gene silencing therapeutics for chronic infections in cystic fibrosis
-
批准号:8511030
-
项目类别:
-
资助金额:$24.83万
-
财政年份:2013
-
负责人:David Elihu Greenberg
-
依托单位:
Gene silencing therapeutics for chronic infections in cystic fibrosis
-
批准号:9248236
-
项目类别:
-
资助金额:$36.08万
-
财政年份:2013
-
负责人:David Elihu Greenberg
-
依托单位:
Gene silencing therapeutics for chronic infections in cystic fibrosis
-
批准号:9039523
-
项目类别:
-
资助金额:$36.69万
-
财政年份:2013
-
负责人:David Elihu Greenberg
-
依托单位:
Novel gene-silencing therapeutics for multidrug-resistant gram-negative pathogens
-
批准号:9055626
-
项目类别:
-
资助金额:$35.97万
-
财政年份:2012
-
负责人:David Elihu Greenberg
-
依托单位:
Novel gene-silencing therapeutics for multidrug-resistant gram-negative pathogens
-
批准号:8842086
-
项目类别:
-
资助金额:$36.55万
-
财政年份:2012
-
负责人:David Elihu Greenberg
-
依托单位:
Novel gene-silencing therapeutics for multidrug-resistant gram-negative pathogens
-
批准号:8823180
-
项目类别:
-
资助金额:$37.21万
-
财政年份:2012
-
负责人:David Elihu Greenberg
-
依托单位:
Novel gene-silencing therapeutics for multidrug-resistant gram-negative pathogens
-
批准号:8267916
-
项目类别:
-
资助金额:$18.61万
-
财政年份:2012
-
负责人:David Elihu Greenberg
-
依托单位:
Novel gene-silencing therapeutics for multidrug-resistant gram-negative pathogens
-
批准号:8463986
-
项目类别:
-
资助金额:$16.77万
-
财政年份:2012
-
负责人:David Elihu Greenberg
-
依托单位:
海外基金